Russia to sell 100 million doses of COVID-19 vaccine to India

Deal comes as India's coronavirus cases surged past 5 million on Wednesday

Russia to sell 100 million doses of COVID-19 vaccine to India

Photo for representational purpose only.

Moscow, September 16

Russia's sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian drug company Dr Reddy's Laboratories, the fund said on Wednesday, as Moscow speeds up plans to distribute its shot abroad.

The deal comes after the Russian Direct Investment Fund (RDIF) reached agreements with Indian manufacturers to produce 300 million doses of the vaccine in India, which is a major consumer of Russian oil and arms.

Dr Reddy's, one of India's top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in India, pending regulatory approval, RDIF said in a statement.

Deliveries to India could begin in late 2020, it said, adding this was subject to the completion of trials and the vaccine's registration by regulatory authorities in India.

Russia was the first country to license a novel coronavirus vaccine before large-scale Phase III trials were complete, stirring concern among scientists and doctors about the safety and efficacy of the shot.

The Phase I and II results had shown promise, G V Prasad, co-chairman of Dr Reddy's, was cited in the RDIF statement as saying.

"Sputnik V vaccine could provide a credible option in our fight against COVID-19 in India," he said.

There was no detail about the price of the vaccine but RDIF has said previously it was not aiming at making a profit, just covering costs.

The agreement comes as India's coronavirus cases surged past 5 million on Wednesday, piling pressure on hospitals grappling with unreliable supplies of oxygen that they need to treat tens of thousands of critical patients.

India is only the second country in the world to cross the grim milestone and said this week it is considering granting an emergency authorisation for a vaccine, particularly for the elderly and people in high-risk workplaces.

The RDIF has already reached vaccine supply deals with Kazakhstan, Brazil and Mexico. It has also signed a memorandum with the Saudi Chemical company.

Russia has billed Sputnik-V as the first vaccine against the coronavirus to be registered in the world. Phase III trials, involving at least 40,000 people, were launched in Russia on Aug. 26 but have yet to be completed. Reuters

Top Stories

'No conclusive proof', all 32 accused acquitted by special court in Babri demolition case

'No conclusive proof', all 32 accused acquitted by special court in Babri demolition case

The case relates to the razing of the disputed structure in ...

Modi tells Yogi govt to take strict action against Hathras gang-rape culprits

Modi tells Yogi govt to take strict action against Hathras gang-rape culprits

UP govt sets up 3-member SIT to probe incident

80,472 new infections in a day push national Covid tally beyond 62 lakh

80,472 new infections in a day push national Covid tally beyond 62 lakh

Death toll rises to 97,497 with 1,179 more fatalities

Maldives thanks India for $250 million support amid Covid pandemic

Maldives thanks India for $250 million support amid Covid pandemic

Minister of Foreign Affairs of Maldives Abdulla Shahid was a...

Cities

View All